Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2021-08-02 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
2021年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the "2021 third extraordinary general meeting of shareholders" of Tian Kang Biological Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and includes a legal opinion from lawyers confirming the legality of the meeting and resolutions. The content focuses on the official voting results and resolutions passed at the shareholders meeting. There is no financial data, no management discussion, no earnings information, nor is it a report or presentation. The document is an official announcement of the voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2098 characters), and it is not merely announcing a report but providing detailed voting results and resolutions. Therefore, the correct classification is DVA with high confidence.
2021-08-02 Chinese
新疆星河律师事务所关于天康生物股份有限公司2021年第三次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and procedures of the 2021 third extraordinary general meeting (临时股东大会) of Tian Kang Biological Co., Ltd. It details the legality of the meeting's notice, attendance, voting procedures, and resolutions passed. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the meeting's compliance with laws and company bylaws. It is related to a shareholders' meeting but is not the meeting materials or voting results announcement itself. Given the nature of the document as a legal opinion letter for a shareholders meeting, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories.
2021-08-02 Chinese
独立董事意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the adjustment of their remuneration, referencing relevant regulatory guidelines and company laws. It is not a full report but a specific statement or opinion related to board/management matters, particularly about director compensation. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG), as it concerns board decisions and management-level disclosures about director remuneration.
2021-07-16 Chinese
关于调整独立董事薪酬的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the adjustment of independent director remuneration by the company's board. It references the board meeting decision and the need for shareholder approval but does not contain detailed remuneration reports or compensation tables. It is a formal announcement about management/board changes related to director pay. Therefore, it fits best under 'Remuneration Information' (DEF 14A) which covers reports detailing compensation for top executives and directors.
2021-07-16 Chinese
关于2021年度为子公司提供银行借款担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tian Kang Biological Co., Ltd. regarding guarantees provided for bank loans to its subsidiaries for the year 2021. It includes details about the guarantee amounts, the subsidiaries involved, financial data of the subsidiaries, board approval, and risk assessment. The document is a formal announcement of a corporate financing-related activity (providing guarantees for loans), but it does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a full audit report or earnings release. The document is also not a regulatory certification or a voting result announcement. Given the content focuses on financing guarantees and related board approvals, the most appropriate classification is a Capital/Financing Update (CAP). The document length is 3624 characters, which is consistent with an announcement rather than a full report. Confidence is high due to clear focus on financing guarantees and board resolutions related to them.
2021-07-16 Chinese
关于召开2021年第三次临时股东大会通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for the 2021 third extraordinary general meeting (临时股东大会) of Tian Kang Bio Co., Ltd. It details the meeting date, voting procedures, agenda items, and proxy voting instructions. It does not contain financial statements or results but is an announcement about the meeting itself and how shareholders can participate and vote. The document length is 4170 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-07-16 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.